James M Kelly

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Radiotherapy Innovations. Top assignee: Cornell University. Active years: 1987-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James M Kelly. Retrieved from https://idiyas.com/inventor/james-m-kelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 93.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 26(Granted Patents)

Location History:

Moab, UT (US) (1987)
Ithaca, NY (US) (2019 - 2020)
New York, NY (US) (2020 - 2022)

Company Filing History:

14 out of 2,954

Cornell University

patents

where one patent can have more than one assignee

Years Active: 1987-2026

Loading Chart...

Areas of Expertise:

Radionuclides

Radiotherapy

Trifunctional Constructs

Tumor Therapies

Macrocyclic Complexes

Targeted Radiotherapy

Pharmacokinetics

PSMA Inhibitors

Imaging Techniques

Cancer Treatment

Double Targeted Constructs

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760012 - Macrocyclic complexes of radionuclides and their use in radiotherapy of cancer (2026-10-13),

2. 12741964 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2026-09-22),

3. 12679812 - F-labeled triazole containing PSMA inhibitors (2026-07-14),

4. 12661417 - Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies (2026-06-23),

5. 12377175 - Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies (2025-08-05),

6. 12268759 - Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies (2025-04-08),

7. 12258339 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2025-03-25),

8. 12186288 - Double targeted constructs to affect tumor kill (2025-01-07),

9. 12103922 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2024-10-01),

10. 11285227 - Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies (2022-03-29),

11. 11279698 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2022-03-22),

12. 10806806 - Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies (2020-10-20),

13. 10716772 - Double targeted constructs to affect tumor kill (2020-07-21),

14. 10179117 - Double targeted constructs to affect tumor kill (2019-01-15),

15. D293045 - Holster production blank (1987-12-08),

Title: The Inventor James M Kelly: Pioneering Innovations in New York

Introduction: James M Kelly is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various industries.

Latest Patents: James M Kelly holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, James M Kelly has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, James M Kelly has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of innovation and creativity.

Conclusion: James M Kelly's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.